Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden (Cancer Immunology, Immunotherapy, (2022), 71, 8, (2029-2040), 10.1007/s00262-021-03139-4)

Julia Femel; Luuk van Hooren; Melanie Herre; Jessica Cedervall; Falk Saupe; Elisabeth J. M. Huijbers; Danielle R. J. Verboogen; Matthias Reichel; Victor L. Thijssen; Arjan W. Griffioen; Lars Hellman; Anna Dimberg; Anna-Karin Olsson

doi:https://doi.org/10.1007/s00262-022-03175-8

Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden (Cancer Immunology, Immunotherapy, (2022), 71, 8, (2029-2040), 10.1007/s00262-021-03139-4)

Julia Femel, Luuk van Hooren, Melanie Herre, Jessica Cedervall, Falk Saupe, Elisabeth J. M. Huijbers, Danielle R. J. Verboogen, Matthias Reichel, Victor L. Thijssen, Arjan W. Griffioen, Lars Hellman, Anna Dimberg, Anna-Karin Olsson

Research output: Contribution to journal › Comment/Letter to the editor › Academic

2 Citations (Scopus)

Abstract

The article Vaccination against galectin-1 promotes cytotoxic T-cell infltration in melanoma and reduces tumor burden, written by Julia Femel, Luuk van Hooren, Melanie Herre, Jessica Cedervall, Falk Saupe, Elisabeth J. M. Huijbers, Danielle R. J. Verboogen, Matthias Reichel, Victor L. Thijssen, Arjan W. Grifoen, Lars Hellman, Anna Dimberg and Anna-Karin Olsson, was originally published electronically on the publisher’s internet portal on 11 January 2021 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 08 February 2022 to

Original language	English
Pages (from-to)	2581
Number of pages	1
Journal	Cancer Immunology, Immunotherapy
Volume	71
Issue number	10
Early online date	2022
DOIs	https://doi.org/10.1007/s00262-022-03175-8
Publication status	Published - Oct 2022

Access to Document

https://doi.org/10.1007/s00262-022-03175-8

Cite this

Femel, J., van Hooren, L., Herre, M., Cedervall, J., Saupe, F., Huijbers, E. J. M., Verboogen, D. R. J., Reichel, M., Thijssen, V. L., Griffioen, A. W., Hellman, L., Dimberg, A., & Olsson, A.-K. (2022). Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden (Cancer Immunology, Immunotherapy, (2022), 71, 8, (2029-2040), 10.1007/s00262-021-03139-4). Cancer Immunology, Immunotherapy, 71(10), 2581. https://doi.org/10.1007/s00262-022-03175-8

@article{d9b6edd3a191446195b47e134f3fe486,

title = "Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden (Cancer Immunology, Immunotherapy, (2022), 71, 8, (2029-2040), 10.1007/s00262-021-03139-4)",

abstract = "The article Vaccination against galectin-1 promotes cytotoxic T-cell infltration in melanoma and reduces tumor burden, written by Julia Femel, Luuk van Hooren, Melanie Herre, Jessica Cedervall, Falk Saupe, Elisabeth J. M. Huijbers, Danielle R. J. Verboogen, Matthias Reichel, Victor L. Thijssen, Arjan W. Grifoen, Lars Hellman, Anna Dimberg and Anna-Karin Olsson, was originally published electronically on the publisher{\textquoteright}s internet portal on 11 January 2021 without open access. With the author(s){\textquoteright} decision to opt for Open Choice the copyright of the article changed on 08 February 2022 to",

author = "Julia Femel and {van Hooren}, Luuk and Melanie Herre and Jessica Cedervall and Falk Saupe and Huijbers, {Elisabeth J. M.} and Verboogen, {Danielle R. J.} and Matthias Reichel and Thijssen, {Victor L.} and Griffioen, {Arjan W.} and Lars Hellman and Anna Dimberg and Anna-Karin Olsson",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = oct,

doi = "https://doi.org/10.1007/s00262-022-03175-8",

language = "English",

volume = "71",

pages = "2581",

journal = "Cancer Immunology, Immunotherapy",

issn = "0340-7004",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "10",

}

Femel, J, van Hooren, L, Herre, M, Cedervall, J, Saupe, F, Huijbers, EJM, Verboogen, DRJ, Reichel, M, Thijssen, VL , Griffioen, AW, Hellman, L, Dimberg, A & Olsson, A-K 2022, 'Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden (Cancer Immunology, Immunotherapy, (2022), 71, 8, (2029-2040), 10.1007/s00262-021-03139-4)', Cancer Immunology, Immunotherapy, vol. 71, no. 10, pp. 2581. https://doi.org/10.1007/s00262-022-03175-8

Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden (Cancer Immunology, Immunotherapy, (2022), 71, 8, (2029-2040), 10.1007/s00262-021-03139-4). / Femel, Julia; van Hooren, Luuk; Herre, Melanie et al.
In: Cancer Immunology, Immunotherapy, Vol. 71, No. 10, 10.2022, p. 2581.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Correction to

T2 - Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden (Cancer Immunology, Immunotherapy, (2022), 71, 8, (2029-2040), 10.1007/s00262-021-03139-4)

AU - Femel, Julia

AU - van Hooren, Luuk

AU - Herre, Melanie

AU - Cedervall, Jessica

AU - Saupe, Falk

AU - Huijbers, Elisabeth J. M.

AU - Verboogen, Danielle R. J.

AU - Reichel, Matthias

AU - Thijssen, Victor L.

AU - Griffioen, Arjan W.

AU - Hellman, Lars

AU - Dimberg, Anna

AU - Olsson, Anna-Karin

PY - 2022/10

Y1 - 2022/10

N2 - The article Vaccination against galectin-1 promotes cytotoxic T-cell infltration in melanoma and reduces tumor burden, written by Julia Femel, Luuk van Hooren, Melanie Herre, Jessica Cedervall, Falk Saupe, Elisabeth J. M. Huijbers, Danielle R. J. Verboogen, Matthias Reichel, Victor L. Thijssen, Arjan W. Grifoen, Lars Hellman, Anna Dimberg and Anna-Karin Olsson, was originally published electronically on the publisher’s internet portal on 11 January 2021 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 08 February 2022 to

AB - The article Vaccination against galectin-1 promotes cytotoxic T-cell infltration in melanoma and reduces tumor burden, written by Julia Femel, Luuk van Hooren, Melanie Herre, Jessica Cedervall, Falk Saupe, Elisabeth J. M. Huijbers, Danielle R. J. Verboogen, Matthias Reichel, Victor L. Thijssen, Arjan W. Grifoen, Lars Hellman, Anna Dimberg and Anna-Karin Olsson, was originally published electronically on the publisher’s internet portal on 11 January 2021 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 08 February 2022 to

UR - http://www.scopus.com/inward/record.url?scp=85125396772&partnerID=8YFLogxK

U2 - https://doi.org/10.1007/s00262-022-03175-8

DO - https://doi.org/10.1007/s00262-022-03175-8

M3 - Comment/Letter to the editor

C2 - 35226107

SN - 0340-7004

VL - 71

SP - 2581

JO - Cancer Immunology, Immunotherapy

JF - Cancer Immunology, Immunotherapy

IS - 10

ER -

Femel J, van Hooren L, Herre M, Cedervall J, Saupe F, Huijbers EJM et al. Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden (Cancer Immunology, Immunotherapy, (2022), 71, 8, (2029-2040), 10.1007/s00262-021-03139-4). Cancer Immunology, Immunotherapy. 2022 Oct;71(10):2581. Epub 2022. doi: https://doi.org/10.1007/s00262-022-03175-8

Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden (Cancer Immunology, Immunotherapy, (2022), 71, 8, (2029-2040), 10.1007/s00262-021-03139-4)

Abstract

Access to Document

Other files and links

Cite this